A detailed history of Bank Of America Corp transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 333,075 shares of AGIO stock, worth $11.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
333,075
Previous 326,780 1.93%
Holding current value
$11.8 Million
Previous $14.1 Million 5.02%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$41.19 - $49.72 $259,291 - $312,987
6,295 Added 1.93%
333,075 $14.8 Million
Q2 2024

Aug 14, 2024

SELL
$27.55 - $48.83 $1.51 Million - $2.68 Million
-54,953 Reduced 14.4%
326,780 $14.1 Million
Q1 2024

May 15, 2024

BUY
$21.32 - $34.81 $3.75 Million - $6.12 Million
175,779 Added 85.35%
381,733 $11.2 Million
Q4 2023

Feb 14, 2024

SELL
$19.97 - $24.53 $939,628 - $1.15 Million
-47,052 Reduced 18.6%
205,954 $4.59 Million
Q2 2023

Aug 14, 2023

SELL
$21.38 - $29.19 $3.64 Million - $4.97 Million
-170,426 Reduced 40.25%
253,006 $7.17 Million
Q1 2023

May 12, 2023

BUY
$21.74 - $30.93 $3.48 Million - $4.95 Million
159,961 Added 60.71%
423,432 $9.73 Million
Q4 2022

Feb 10, 2023

SELL
$24.81 - $31.52 $494,364 - $628,067
-19,926 Reduced 7.03%
263,471 $7.4 Million
Q3 2022

Nov 14, 2022

BUY
$19.51 - $34.14 $2.37 Million - $4.14 Million
121,236 Added 74.76%
283,397 $8.02 Million
Q2 2022

Aug 12, 2022

SELL
$17.06 - $31.42 $1.79 Million - $3.3 Million
-104,976 Reduced 39.3%
162,161 $3.6 Million
Q1 2022

May 16, 2022

SELL
$26.68 - $34.81 $401,347 - $523,646
-15,043 Reduced 5.33%
267,137 $7.78 Million
Q4 2021

Feb 08, 2022

BUY
$29.58 - $49.78 $4.31 Million - $7.25 Million
145,719 Added 106.78%
282,180 $9.28 Million
Q3 2021

Nov 15, 2021

SELL
$41.92 - $58.18 $1.24 Million - $1.73 Million
-29,655 Reduced 17.85%
136,461 $6.3 Million
Q2 2021

Sep 13, 2021

BUY
$52.06 - $61.27 $8.65 Million - $10.2 Million
166,116 New
166,116 $9.16 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.94B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.